GLOFITAMAB-GXBM vs GLUCARPIDASE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLOFITAMAB-GXBM vs GLUCARPIDASE: Safety Overview
| Metric | GLOFITAMAB-GXBM | GLUCARPIDASE |
|---|---|---|
| Total FAERS Reports | 498 | 275 |
| Deaths Reported | 175 | 41 |
| Death Rate | 35.1% | 14.9% |
| Hospitalizations | 113 | 52 |
| Average Patient Age | 60.0 yrs | 44.3 yrs |
| % Female Patients | 36.2% | 36.4% |
| Manufacturer | N/A | BTG International Inc. |
| Route | N/A | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |